Thursday, October 28

1:00 – 1:45 pm

Table Talk: Remaining True to Your Passion & Goals as Pediatric Hematology/Oncology Nurses (CDE)

Calling all Attendees to an interactive discussion —Table Talk: moving forward in the ever-changing world of nursing. How do we remain true to our passion and goals and continue to develop as hematology/oncology nurses?
Speaker:

Mary E Newman, MSN RN CPON®

Deborah A. Lafond, DNP CHPPN PPCNP-BC CPON®

 

Meredith Foxx, MSN MBA PCNS-BC APRN PPCNP-BC CPON®

Angie Blackwell, MSN RN CNS CPON®

Misty Evans, DNP APRN CPNP-AC BMTCN®

 

Cecilia A. Gladbach, BSN RN BMTCN CPON®

Janice Nuuhiwa, MSN APN NBD-BC CNS CPHON®

 

CNE Hours
.75
3:30 – 4:30 pm

Administration and Management of Anti-GD2 Immunotherapy for High Risk Neuroblastoma in the Outpatient Setting (200)

Neuroblastoma, the most common extracranial solid tumor in children, develops from neural crest cells that, typically, differentiate to form the sympathetic nervous system. Most neuroblastoma cases present as high-risk neuroblastoma, which has long been associated with high relapse rates and poor survival.

3:30 – 4:30 pm

Joint Topic: Error Prevention — Decreasing CLABSI through inter-specialty nurse rounding (201-1)

Central lines are integral in the delivery of chemotherapy and supportive care for pediatric oncology patients. However, central lines are associated with increased morbidity and mortality, especially in immunocompromised children. After a spike in central line–associated bloodstream infections (CLABSIs) in our hospital, our harm prevention department required weekly checks of every central line.